Terri Pollack

Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma

Moh’d Khushman, Naomi Dempsey, Jennifer Cudris Maldonado et al. · Pancreatology · 2015 · 80 citations

Surgical Oncology, Pancreatic Cancer, Gastrointestinal Oncology +8

Severe intra-abdominal bleeding following stapled mucosectomy due to enterocele: report of a case

Georg Aumann, Sven Petersen, Terri Pollack et al. · Techniques in Coloproctology · 2004 · 39 citations

Gastrointestinal Bleeding, Gastroenterology, Digestive System Surgery +6

Neoadjuvant <i>Nab</i>-paclitaxel and Gemcitabine in Borderline Resectable or Locally Advanced Unresectable Pancreatic Adenocarcinoma in Patients Who Are Ineligible for FOLFIRINOX

Shawn Peterson, Muhammad Husnain, Terri Pollack et al. · Anticancer Research · 2018 · 16 citations · Full text

The nab-paclitaxel/gemcitabine regimen for patients with refractory advanced pancreatic adenocarcinoma

Sofia Palacio, Peter J. Hosein, Isildinha M. Reis et al. · Journal of Gastrointestinal Oncology · 2018 · 14 citations · Full text

Exceptional responses to ipilimumab/nivolumab (ipi/nivo) in patients (pts) with refractory pancreatic ductal adenocarcinoma (PDAC) and germline BRCA or RAD51 mutations.

Gretel Terrero, Terri Pollack, Daniel A. Sussman et al. · Journal of Clinical Oncology · 2020 · 10 citations

Exceptional Responses, Immunology, Pathology +17